Our results showed that low NBR1 expression could be a potential prognostic factor for ccRCC patients with N0 stage (Figure 4B, p < 0.0001), non-metastasis (Figure 4C, p < 0.0001), metastasis (Figure 4D, p = 0.0108), T1 + T2 stage (Figure 4E, p = 0.0092), T3 + T4 stage (Figure 4F, p = 0.0003), TNM (I+II) (Figure 4G, p = 0.0368), TNM (III+IV) stage (Figure 2H, p = 0.0004), Male (Figure 4I, p = 0.0001), female (Figure 4J, p < 0.0001), Age > 60 years (Figure 4K, p < 0.0001), Age ≤ 60 years (Figure 4L, p = 0.0007), G3+G4 stage (Figure 4M, p < 0.0001). This evidence concerns the gene NBR1 and nonpapillary renal cell carcinoma.